03/29/2023
By Sanjeev Manohar

You are invited to a seminar by Seongkyu Yoon titled "Who is making $200k+ salary in Boston? Massachusetts Biotech Industry, Current and Forecast." This will be an excellent information session for those interested in careers in the biopharmaceutical industry.

Thursday, March 30,2023
Shah Hall 310

Abstract:
Research in Yoon's group focuses on accelerating biopharmaceutical manufacturing innovation, supporting the development of standards that enable more efficient and rapid manufacturing capabilities, and educating/training a world-leading biopharmaceutical manufacturing workforce, and fundamentally advancing U.S. competitiveness in this industry. Emphasis is also on driving down costs and risks associated with manufacturing biologics, including proteins, cell-based therapeutics, and vectored gene therapies.

The seminar is about Massachusetts Biotech Industry Overview and Forecast and will address 1) how Massachusetts biotech industry originated, 2) what is the current ecosystem in terms of statistics and measures, 3) how will this ecosystem progress in the future, and 4) challenges and overcoming strategies. For those of you who are pursuing careers in biopharmaceutical industry, this talk will be an excellent information session.


Biography:
DSeongkyu Yoon is a Professor in the Chemical Engineering Department in the Francis College of Engineering at the University of Massachusetts Lowell which he joined in 2010 after 15 years in industry. Yoon is co-director of Massachusetts Biomanufacturing Center, the UMass site director of the NSF/IUCRC/AMBIC (Advanced Mammalian Biomanufacturing Innovation Center), the co-PI of NSF/AccelNet/IBioNe (International Biomanufacturing Network), and the UMass technical lead for NIST-sponsored Manufacturing USA institute NIIMBL. Dr. Yoon founded the Massachusetts-based Biomanufacturing Innovation Institute and is leading a research group of systems and synthetic biology while conducting research in platform process development for protein, gene and vaccine therapeutics. He completed his Ph.D. at McMaster University (Hamilton, Canada), and MBA from Babson College (Wellesley, MA).